Refractory hypercalcemia presumably caused by metastasizing cancer of the prostate
Højhus, J.H.; Orthmann-Brask, H.
Ugeskrift for Laeger 143(41): 2658
1981
ISSN/ISBN: 0041-5782 PMID: 7303294 Document Number: 175642
Document emailed within 1 workday
Related Documents
Grzywacz, A.; Dziuk, M.ła.; Niemczyk, S.ła. 2014: Refractory hypercalcemia in patient with lung cancer Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 36(214): 261-264Ngo, L.S.M.; Yeo, A.; Wong, A.S.C.; Tay, M.Hiang. 2007: Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, Singapore Annals of the Academy of Medicine Singapore 36(10): 811-814
De la Piedra, C.; Rapado, A.; Esbrit, P. 1985: Serum levels of osteocalcin in hypercalcemia caused by primary hyperparathyroidism and in tumor hypercalcemia Revista Clinica Espanola 177(7): 310-313
Arena, F. 2008: Dutasteride in the treatment of hormone refractory prostate cancer Minerva Urologica e Nefrologica 60(2): 71-76
Roth, B.J. 1996: New therapeutic agents for hormone-refractory prostate cancer Seminars in Oncology 23(6 Suppl 14: 49-55
Song, H.-z.; Chen, L.-b. 2007: Advances in researches on hormonal refractory prostate cancer Zhonghua Nan Ke Xue 13(1): 57-60
Wilkes, G.M. 2010: Cabazitaxel, a taxane for men with hormone-refractory metastatic prostate cancer Oncology 24(10 Suppl): 46-48
Ross, R.W.; Kantoff, P.W. 2007: Hormone-refractory prostate cancer: choosing the appropriate treatment option Oncology 21(2): 185-193; Discussion 194: 199-200
Dexeus, F.; Logothetis, C.J.; Samuels, M.L.; Hossan, E.; von Eschenbach, A.C. 1985: Continuous infusion of vinblastine for advanced hormone-refractory prostate cancer Cancer Treatment Reports 69(7-8): 885-886
Yang, N-qin.; Wang, Y-xin. 2006: Current situation of researches on the molecule mechanism of hormone refractory prostate cancer Zhonghua Nan Ke Xue 12(6): 551-554
Kelly, W.K. 1998: Endocrine withdrawal syndrome and its relevance to the management of hormone refractory prostate cancer European Urology 34(Suppl): 18-23
Fujinami, K.; Miura, T.; Takizawa, A.; Osada, Y. 2005: Combination chemotherapy with docetaxel and cisplatin in patients with hormone-refractory prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 51(1): 5-8
Boehmer, A.; Anastasiadis, A.G.; Feyerabend, S.; Nagele, U.; Kuczyk, M.; Schilling, D.; Corvin, S.; Merseburger, A.S.; Stenzl, A. 2005: Docetaxel, estramustine and prednisone for hormone-refractory prostate cancer: a single-center experience Anticancer Research 25(6c): 4481-4486
Awakura, Y.; Yamamoto, M.; Fukuzawa, S.; Itoh, N.; Nonomura, M.; Fukuyama, T. 2000: Clinical evaluation of estramustine phosphate and vinblastine in patients with hormone-refractory prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 46(7): 449-452
Kawaguchi, T.; Mayama, I.; Iwabuchi, I.; Ogasawara, M.; Tsukui, A. 2010: Chemo-endocrine therapy with low-dose cisplatin, UFT, and dexamethasone for hormone-refractory prostate cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 37(10): 1921-1925
Colombel, M.; Davin, J.-L.; Filleul, A.; Rousseau, C. 2004: Diagnosis and management of advanced hormone-refractory prostate cancer: results of a practice survey on 301 French urologists Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 14(2): 182-188
Miglietta, L.; Cannobbio, L.; Boccardo, F. 1995: Assessment of response to carboplatin in patients with hormone-refractory prostate cancer: a critical analysis of drug activity Anticancer Research 15(6b): 2825-2828
Sinibaldi, V.J.; Carducci, M.; Laufer, M.; Eisenberger, M. 1999: Preliminary evaluation of a short course of estramustine phosphate and docetaxel (Taxotere) in the treatment of hormone-refractory prostate cancer Seminars in Oncology 26(5 Suppl 17: 45-48
Coccaro, M.; Tartarone, A.; Romano, G.; Ardito, R.; Di Renzo, N. 2005: Dose-finding study of weekly docetaxel plus estramustine in patients with hormone-refractory metastatic prostate cancer Tumori 91(4): 314-316
Heimbach, D.; Wirth, M.; Frohmüller, H. 1991: Chemotherapy in metastasizing prostate carcinoma Der Urologe. Ausg. a 30(5): 329-332